Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020

BACKGROUND: A pillar of the United States’ Ending the HIV Epidemic (EHE) initiative is to rapidly provide antiretroviral therapy (ART) in order to achieve HIV viral suppression. However, insurance benefit design can impede ART access. The primary objective of this study is to understand how Affordab...

Descripción completa

Detalles Bibliográficos
Autores principales: Khazanchi, Rohan, Powers, Samuel, Killelea, Amy, Strumpf, Andrew, Horn, Tim, Hamp, Auntré, McManus, Kathleen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116786/
https://www.ncbi.nlm.nih.gov/pubmed/37081570
http://dx.doi.org/10.1186/s40545-023-00559-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116786/
https://www.ncbi.nlm.nih.gov/pubmed/37081570
http://dx.doi.org/10.1186/s40545-023-00559-8

Ejemplares similares